Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUITSPIT study of glycopyrronium bromide for nocturnal clozapine-induced sialorrhea
2012-002299-15Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of glycopyrronium in hypersalivation (3 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Clinically significant improvement in nocturnal sialorrhea severity. Started Jul 2012; status: completed.
02
Drugs
glycopyrronium
03
Conditions
hypersalivation
Beyond the preview
Go deeper on 2012-002299-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002299-15.